Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
64.413,42
-0,68%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
23/11/201623:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BPMCBlueprint Medicines Corporation
15/11/201612:00PR Newswire (US)Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NC...NASDAQ:BPMCBlueprint Medicines Corporation
14/11/201623:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
14/11/201622:01PR Newswire (US)Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph...NASDAQ:BPMCBlueprint Medicines Corporation
10/11/201622:56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
10/11/201613:00PR Newswire (US)Blueprint Medicines Reports Third Quarter 2016 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
03/11/201621:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
03/11/201621:01PR Newswire (US)Blueprint Medicines to Report Third Quarter 2016 Financial Results on Thursday, November 10, 2016NASDAQ:BPMCBlueprint Medicines Corporation
03/11/201614:01PR Newswire (US)Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocyt...NASDAQ:BPMCBlueprint Medicines Corporation
25/10/201618:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BPMCBlueprint Medicines Corporation
19/09/201623:25Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BPMCBlueprint Medicines Corporation
09/09/201614:30PR Newswire (US)Blueprint Medicines Announces New Drug Discovery Program Targeting PRKACA Kinase Fusions for the Treatment of Fibrolamellar C...NASDAQ:BPMCBlueprint Medicines Corporation
07/09/201614:30PR Newswire (US)Blueprint Medicines to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
06/09/201622:01PR Newswire (US)Blueprint Medicines Announces Appointment of Tracey McCain as Chief Legal Officer and Executive Vice PresidentNASDAQ:BPMCBlueprint Medicines Corporation
09/08/201613:00PR Newswire (US)Blueprint Medicines Reports Second Quarter 2016 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
03/08/201614:00PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in AugustNASDAQ:BPMCBlueprint Medicines Corporation
02/08/201614:00PR Newswire (US)Blueprint Medicines to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016NASDAQ:BPMCBlueprint Medicines Corporation
26/07/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BPMCBlueprint Medicines Corporation
22/07/201622:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:BPMCBlueprint Medicines Corporation
22/07/201622:17Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:BPMCBlueprint Medicines Corporation
01/06/201622:05PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in JuneNASDAQ:BPMCBlueprint Medicines Corporation
10/05/201623:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BPMCBlueprint Medicines Corporation
10/05/201613:00PR Newswire (US)Blueprint Medicines Reports First Quarter 2016 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
03/05/201623:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
03/05/201614:00PR Newswire (US)Blueprint Medicines to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016NASDAQ:BPMCBlueprint Medicines Corporation
28/04/201622:43Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BPMCBlueprint Medicines Corporation
28/04/201622:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BPMCBlueprint Medicines Corporation
15/04/201614:00PR Newswire (US)Blueprint Medicines Appoints Lynn Seely, M.D. to Board of DirectorsNASDAQ:BPMCBlueprint Medicines Corporation
05/04/201614:00PR Newswire (US)Blueprint Medicines to Present at 15th Annual Needham Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
28/03/201623:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
FBK
Finecobank
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network